First major milestone reached for Reacta Healthcare £1m Innovate UK funded project

Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater...

Senior hire to cement 2023 growth plans at Reacta Healthcare

Reacta Healthcare has appointed a new quality control manager to further expand and develop its...

My time at MEDICA 2022

By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare   Last month I had the...

Development Bank of Wales ramping up tech equity deals since the lockdown

The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most...

Reacta Healthcare secures first US patent

Reacta Healthcare, based in Deeside North Wales, has secured its first US patent, expanding patents...

Praetura Ventures leads £2.9m investment in food allergy diagnostic firm

Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a...

UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA Pharma GMP accreditation

Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an...

Reacta Biotech making progress on peanut diagnostic product

Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic...

Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics

The £1 million grant will support the development of the first Oral Food Challenges (OFCs)...

UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans

We share relevant third party stories on our website. This release was written and issued...